Positive Results in Proof-of-Concept Study with Sustained Release Treatment for Uveitis
23-Feb-2015 -
Midatech Pharma announced positive results from a proof-of-concept in vivo study with OpsiSporin, a sustained release treatment for uveitis. Uveitis is an inflammatory process affecting the iris, the ciliary body, the choroid layer or all or part of these structures of the eye. Whilst treatments ...
microencapsulation
uveitis